Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 7935
TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224619(US9326978, 32)
Affinity DataKi:  410nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224617(US9326978, 30)
Affinity DataKi:  786nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224618(US9326978, 31)
Affinity DataKi:  1.19E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224621(US9326978, 34)
Affinity DataKi:  1.61E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224617(US9326978, 30)
Affinity DataKi:  3.15E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224617(US9326978, 30)
Affinity DataKi:  3.42E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224618(US9326978, 31)
Affinity DataKi:  3.85E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224619(US9326978, 32)
Affinity DataKi:  4.17E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi:  4.69E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi:  4.69E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224618(US9326978, 31)
Affinity DataKi:  5.22E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224621(US9326978, 34)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224619(US9326978, 32)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224621(US9326978, 34)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent